⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homocysteine SCHEMBL28927454 | 1.00 | PTGS1 (0.62) | — | |
| L-Homocysteine SCHEMBL936366 | 1.00 | PTGS1 (0.62) | — | |
| Homocysteine SCHEMBL35836 | 1.00 | — | — | |
| L-Homocysteine SCHEMBL35837 | 1.00 | — | — | |
| Homocysteine SCHEMBL936365 | 1.00 | PTGS1 (0.62) | — | |
| L-Homocysteine SCHEMBL23721811 | 0.97 | PTGS1 (0.59) | — | |
| Homocysteine SCHEMBL3326967 | 0.97 | — | — | |
| Homocysteine SCHEMBL2513065 | 0.97 | PTGS1 (0.59) | — | |
| L-Homocysteine SCHEMBL2513063 | 0.97 | PTGS1 (0.59) | — | |
| Homocysteine SCHEMBL1534779 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 800 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2026-03-26 | — | — | US | claimed |
| EP-4711004-A2 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Rhythm Pharmaceuticals, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260001915-A1 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS INC (US) | 2026-01-01 | — | — | US | claimed |
| US-20250195606-A1 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2025-06-19 | — | — | US | claimed |
| CN-120152725-A | Methods of treating obesity using MC4R agonists | 节奏制药公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250163103-A1 | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS | KAI PHARMACEUTICALS, INC. | 2025-05-22 | — | — | US | claimed |
| EP-4554607-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | Rhythm Pharmaceuticals, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| US-20250129125-A1 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2025-04-24 | — | — | US | claimed |
| WO-2025072586-A1 | CHAIN TRANSFER AGENTS AND METHODS OF PREPARING THE SAME | ARKEMA INC. (US) | 2025-04-03 | — | — | WO | claimed |
| US-12263202-B2 | Method of treating melanocortin-4 receptor pathway-associated disorders | RHYTHM PHARMACEUTICALS, INC. (US) | 2025-04-01 | — | — | US | claimed |
| US-20090176715-A1 | Pharmaceutical Compositions and Methods Utilizing a D-Amino Acid | AMINO ACIDS SOLUTIONS INC. (US) | 2009-07-09 | — | — | US | claimed |
| US-7335292-B2 | Metal electrode coated with an organosulfur compounds, especially 2-mercaptoethanol, 2-mercaptoethylamine, 3-mercaptopropionic acid, thiophene, cysteine, homocysteine, 3-carboxythiophene, or cystine; surfactant overcoating | LIFESCAN, INC. (US) | 2008-02-26 | — | — | US | claimed |
| US-7163920-B2 | Peptide with osteogenic activity | ETHICON, INC. (US) | 2007-01-16 | — | — | US | claimed |
| US-20060040324-A1 | Methods for making metallopeptides and metallopeptide libraries | PALATIN TECHNOLOGIES, INC. (US) | 2006-02-23 | — | — | US | claimed |
| US-20050187162-A1 | Novel peptide with osteogenic activity | ETHICON, INC. | 2005-08-25 | — | — | US | claimed |
| WO-2005032461-A2 | NOVEL PEPTIDE WITH OSTEOGENIC ACTIVITY | ETHICON, INC. (US) | 2005-04-14 | — | — | WO | claimed |
| US-4605625-A | RACEMIZATION WITH PSEUDOMONAS | NIPPON ZEON CO., LTD. (JP) | 1986-08-12 | — | — | US | claimed |
| EP-0010668-B1 | 3-DEAZAADENOSINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-01-22 | — | — | EP | claimed |
| US-4309419-A | 3-DEAZA-ADENOSINE | BURROUGHS WELLCOME CO. (US) | 1982-01-05 | — | — | US | claimed |
| EP-0010668-A1 | 3-Deazaadenosine and pharmaceutical compositions containing it | THE WELLCOME FOUNDATION LIMITED (GB) | 1980-05-14 | — | — | EP | claimed |